Reporting on adverse events (TAM-Vigilance)
The duty to report adverse events to Swissmedic is specified in Article 59 of the Law on Therapeutic Products of 15 December 2000 (HMG) and in articles 61-66 of the Ordinance on Therapeutic Products of 21 September 2018 (VAM).